Literature DB >> 26526784

Effect of the Pulsatile Extracorporeal Membrane Oxygenation on Hemodynamic Energy and Systemic Microcirculation in a Piglet Model of Acute Cardiac Failure.

Hideshi Itoh1,2, Shingo Ichiba3, Yoshihito Ujike2, Takuma Douguchi4, Hideaki Obata5, Syuji Inamori1, Tatsuo Iwasaki6, Shingo Kasahara4, Shunji Sano4, Akif Ündar7.   

Abstract

The objective of this study was to compare the effects of pulsatile and nonpulsatile extracorporeal membrane oxygenation (ECMO) on hemodynamic energy and systemic microcirculation in an acute cardiac failure model in piglets. Fourteen piglets with a mean body weight of 6.08 ± 0.86 kg were divided into pulsatile (N = 7) and nonpulsatile (N = 7) ECMO groups. The experimental ECMO circuit consisted of a centrifugal pump, a membrane oxygenator, and a pneumatic pulsatile flow generator system developed in-house. Nonpulsatile ECMO was initiated at a flow rate of 140 mL/kg/min for the first 30 min with normal heart beating, with rectal temperature maintained at 36°C. Ventricular fibrillation was then induced with a 3.5-V alternating current to generate a cardiac dysfunction model. Using this model, we collected the data on pulsatile and nonpulsatile groups. The piglets were weaned off ECMO at the end of the experiment (180 min after ECMO was initiated). The animals did not receive blood transfusions, inotropic drugs, or vasoactive drugs. Blood samples were collected to measure hemoglobin, methemoglobin, blood gases, electrolytes, and lactic acid levels. Hemodynamic energy was calculated using the Shepard's energy equivalent pressure. Near-infrared spectroscopy was used to monitor brain and kidney perfusion. The pulsatile ECMO group had a higher atrial pressure (systolic and mean), and significantly higher regional saturation at the brain level, than the nonpulsatile group (for both, P < 0.05). Additionally, the pulsatile ECMO group had higher methemoglobin levels within the normal range than the nonpulsatile group. Our study demonstrated that pulsatile ECMO produces significantly higher hemodynamic energy and improves systemic microcirculation, compared with nonpulsatile ECMO in acute cardiac failure.
Copyright © 2015 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  Extracorporeal membrane oxygenation; Hemodynamic energy; Pediatric; Pulsatile; Systemic microcirculation

Mesh:

Year:  2015        PMID: 26526784     DOI: 10.1111/aor.12588

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  10 in total

1.  The association of early post-resuscitation hypotension with discharge survival following targeted temperature management for pediatric in-hospital cardiac arrest.

Authors:  Alexis A Topjian; Russell Telford; Richard Holubkov; Vinay M Nadkarni; Robert A Berg; J Michael Dean; Frank W Moler
Journal:  Resuscitation       Date:  2019-06-05       Impact factor: 5.262

Review 2.  Hemodynamic adaptation of heart failure to percutaneous venoarterial extracorporeal circulatory supports.

Authors:  P Hála; O Kittnar
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

3.  Coagulopathy Characterized by Rotational Thromboelastometry in a Porcine Pediatric ECMO Model.

Authors:  Christopher R Reed; Desiree Bonadonna; Jeffrey Everitt; Victoria Robinson; James Otto; Elisabeth T Tracy
Journal:  J Extra Corpor Technol       Date:  2020-09

4.  A Computational Fluid Dynamics Study of the Extracorporeal Membrane Oxygenation-Failing Heart Circulation.

Authors:  Farhad Rikhtegar Nezami; Farhan Khodaee; Elazer R Edelman; Steven P Keller
Journal:  ASAIO J       Date:  2021-03-01       Impact factor: 3.826

5.  Electrocardiogram-synchronized pulsatile extracorporeal life support preserves left ventricular function and coronary flow in a porcine model of cardiogenic shock.

Authors:  Petr Ostadal; Mikulas Mlcek; Holger Gorhan; Ivo Simundic; Svitlana Strunina; Matej Hrachovina; Andreas Krüger; Dagmar Vondrakova; Marek Janotka; Pavel Hala; Martin Mates; Martin Ostadal; James C Leiter; Otomar Kittnar; Petr Neuzil
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

6.  Microfluidic cell sorting: Towards improved biocompatibility of extracorporeal lung assist devices.

Authors:  Christian Bleilevens; Jonas Lölsberg; Arne Cinar; Maren Knoben; Oliver Grottke; Rolf Rossaint; Matthias Wessling
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

7.  Acute right heart failure: future perspective with the PERKAT RV pulsatile right ventricular support device.

Authors:  Markus W Ferrari; P Christian Schulze; Daniel Kretzschmar
Journal:  Ther Adv Cardiovasc Dis       Date:  2020 Jan-Dec

Review 8.  Heart failure supported by veno-arterial extracorporeal membrane oxygenation (ECMO): a systematic review of pre-clinical models.

Authors:  Silver Heinsar; Sacha Rozencwajg; Jacky Suen; Gianluigi Li Bassi; Maximilian Malfertheiner; Leen Vercaemst; Lars Mikael Broman; Matthieu Schmidt; Alain Combes; Indrek Rätsep; John F Fraser; Jonathan E Millar
Journal:  Intensive Care Med Exp       Date:  2020-05-25

9.  Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup.

Authors:  Michael Joannidis; Lui G Forni; Sebastian J Klein; Patrick M Honore; Kianoush Kashani; Marlies Ostermann; John Prowle; Sean M Bagshaw; Vincenzo Cantaluppi; Michael Darmon; Xiaoqiang Ding; Valentin Fuhrmann; Eric Hoste; Faeq Husain-Syed; Matthias Lubnow; Marco Maggiorini; Melanie Meersch; Patrick T Murray; Zaccaria Ricci; Kai Singbartl; Thomas Staudinger; Tobias Welte; Claudio Ronco; John A Kellum
Journal:  Intensive Care Med       Date:  2019-12-09       Impact factor: 17.440

10.  Temporary right ventricular circulatory support following right ventricular infarction: results of a groin-free approach.

Authors:  Jamila Kremer; Mina Farag; Andreas Brcic; Alina Zubarevich; Joel Schamroth; Michael M Kreusser; Matthias Karck; Arjang Ruhparwar; Bastian Schmack
Journal:  ESC Heart Fail       Date:  2020-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.